1 Product identity
Ingredient risk
1 ingredient to use with caution

Magnesium Potassium Aspartate

BrandCountry Life Target-MinsMineral Tablet or Pill 9 ingredients 1 caution DSLD #333314
Net contents: 90 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-09-25
2 Ingredients (9)
IngredientGroupSafety
MagnesiumMagnesiumUse with Caution
PotassiumPotassiumConditionally Safe
CelluloseCellulose
Stearic AcidStearic Acid
HypromelloseHypromellose
GlycerinGlycerol
SilicaSiliconGenerally Safe
Magnesium StearateMagnesiumUse with Caution
Vegetable GlazeCoating
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Potassium — Conditionally Safe
⚠ Hyperkalemia risk
⚠ Dangerous with ACE inhibitors
Silicon — Generally Safe
⚠ Very low toxicity
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID333314
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-09-25
6 More from Country Life Target-Mins
View Country Life Target-Mins Safety Scorecard → 3 products
Calcium 1,000 mg Magnesium 500 mg Zinc 25 mg with Vitamin DMagnesium Potassium Aspartate
7 Cite this page
Vancouver
Pkhakadze G. Magnesium Potassium Aspartate — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 01]. Available from: https://supplement.ge/products/dsld-333314/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG